Compton Capital Management’s Boston Scientific BSX Stock Holding History

Compton Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,365	Closed	-$248K	–	55
2022 Q4	$248K	Sell	5,365 -500	-9%	-$21.7K	0.18%	68
2022 Q3	$227K	Sell	5,865 -125	-2%	-$5.01K	0.15%	76
2022 Q2	$223K	Sell	5,990 -1,500	-20%	-$61.1K	0.12%	92
2022 Q1	$332K	Hold	7,490	–	–	0.09%	138
2021 Q4	$318K	Hold	7,490	–	–	0.08%	142
2021 Q3	$325K	Sell	7,490 -270	-3%	-$11.9K	0.1%	138
2021 Q2	$332K	Buy	7,760 +175	+2%	+$7.36K	0.1%	134
2021 Q1	$293K	Buy	7,585 +75	+1%	+$2.84K	0.09%	134
2020 Q4	$270K	Buy	7,510 +350	+5%	+$12.6K	0.09%	129
2020 Q3	$274K	Sell	7,160 -300	-4%	-$11.6K	0.11%	116
2020 Q2	$262K	Buy	7,460 +300	+4%	+$10.8K	0.11%	114
2020 Q1	$234K	Buy	7,160 +600	+9%	+$23.4K	0.12%	114
2019 Q4	$297K	Buy	+6,560	New	+$274K	0.12%	115

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Compton Capital Management's BSX Position: Q1 2023 in Review

Compton Capital Management sold out of Boston Scientific (BSX) in Q1 2023, closing a stake of 5,365 shares — an estimated $248K sold.

Compton Capital Management first reported a position in BSX in Q4 2019 and held it in 13 quarters. The position peaked at $332K in Q1 2022. 997 funds tracked by Wall St. Rank hold BSX as of Q1 2023.

Compton Capital Management reported no remaining Boston Scientific position as of Q1 2023 after selling out during the quarter.
Compton Capital Management sold 5,365 Boston Scientific shares in Q1 2023, an estimated $248K.
Compton Capital Management first reported a position in Boston Scientific in Q4 2019 and held it in 13 quarters.
Compton Capital Management's Boston Scientific position peaked at $332K in Q1 2022.
997 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2023.

Based on Compton Capital Management's 13F filing for Q1 2023, filed 9 May 2023.